Jiwoo Jung

Jiwoo Jung

Auto-generated profile, based on publicly available information

Jiwoo Jung

ROWAN Inc., Seoul, Korea

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 January 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
SMSo Young Moon
So Young Moon
Yoo Kyoung ParkYoo Kyoung Park
Yoo Kyoung Park
JJJee Hyang Jeong
Jee Hyang Jeong
CHChang Hyung Hong
Chang Hyung Hong
JJJiwoo Jung
Jiwoo Jung
SCSeong Hye Choi
Seong Hye Choi
INTRODUCTION: We investigated the efficacy of a multidomain intervention (MI) via face‐to‐face and video communication platforms using a tablet personal computer application in patients with mild cognitive impairment (MCI). METHODS: Three hundred participants with MCI and ≥ 1 modifiable dementia risk factor, aged 60‐85 years, were randomly assigned to either the MI group, who underwent a 24‐week intervention, or the control group, who received usual care. RESULTS: The overall adherence rate to MI was 84.7%. The adjusted mean change from baseline at 24 weeks in the total scale index score of the repeatable battery for the assessment of neuropsychological status was 8.43 in the MI group and 4.26 in the control group (difference, 4.17; 95% confidence interval, 1.92‐6.43; p < 0.001). MI showed significant beneficial effects on cognition in both apolipoprotein E (APOE) ε4 carriers and noncarriers. DISCUSSION: MI can exert beneficial effects on the cognition of patients with MCI. Trial Registration : ClinicalTrials.gov identifier: NCT05023057 Highlights: Although the controls also demonstrated improved performance in cognition, multidomain interventions showed significantly greater benefits for cognition in MCI compared to the controls in a randomized controlled trial. Multidomain interventions improved depression and quality of life. Multidomain interventions significantly positively impacted cognition in both APOE ε4 carriers and noncarriers. Multidomain interventions may be more effective for amnestic than nonamnestic MCI.

1 January 2024 in Dementia and Neurocognitive Disorders
Verified
Journal Article
Open access
PDF file
SCSoo Hyun Cho
Soo Hyun Cho
HKHae Jin Kang
Hae Jin Kang
Yoo Kyoung ParkYoo Kyoung Park
Yoo Kyoung Park
SMSo Young Moon
So Young Moon
CHChang Hyung Hong
Chang Hyung Hong
SCSeong Hye Choi
Seong Hye Choi
Cho SH, et al. Dement Neurocogn Disord. 2024 Jan;23(1):30-43. https://doi.org/10.12779/dnd.2024.23.1.30

6 January 2026 in Digital Health
Verified
Journal Article
Open access
SJSoyoung Jung
Soyoung Jung
HKHae Jin Kang
Hae Jin Kang
SMSo Young Moon
So Young Moon
Muncheong ChoiMuncheong Choi
Muncheong Choi
JJJiwoo Jung
Jiwoo Jung
Yoo Kyoung ParkYoo Kyoung Park
Yoo Kyoung Park
Objective: The rapid global aging trend has led to a substantial increase in the prevalence of frailty among older adults. We developed a mobile app-based multidomain intervention (MI) program as part of a South Korean study to prevent the progression of frailty and aging-related diseases using a digital MI (SUPERAGING). We aim to evaluate the feasibility of the SUPERAGING app-based intervention in prefrail or frail older adults. Methods: We will recruit 40 community-dwelling older adults aged 60 to 90 years classified as frail or prefrail according to the Modified Fried frailty criteria. Participants will be randomly assigned to intervention and control groups at a 1:1 ratio. The intervention group will receive a personalized program through the SUPERAGING digital platform, comprising four components: disease management, cognitive training, physical exercise and nutritional intervention for 16 weeks. The control group will receive standard lifestyle education only. The primary outcomes are adherence, retention, and recruitment rates. The main secondary outcomes are frailty, disability, cognitive function, physical performance, nutritional assessment, mood, quality of life, vascular risk factors, and occurrence of aging-related diseases. There will be an exploratory evaluation of biological aging markers. Results: The intervention program will be considered feasible if the following success criteria are met: (a) a retention rate of 70% or higher, (b) an adherence rate of 70% or higher, and (c) a recruitment rate of 50% or higher. Conclusions: The results will provide information on the applicability of a MI using a mobile app targeting older adults with prefrailty or frailty. Trial registration: ClinicalTrials.gov identifier: NCT06891573. Registered on February 25, 2025.

20 July 2026 in Neurology
Verified
Journal Article
Closed access
PDF file
DKDa Ae Kim
Da Ae Kim
SLSun Min Lee
Sun Min Lee
KSKyunghwa Sun
Kyunghwa Sun
JPJi Hyun Park
Ji Hyun Park
Yoo Kyoung ParkYoo Kyoung Park
Yoo Kyoung Park
SMSo Young Moon
So Young Moon
Background and ObjectivesMild cognitive impairment (MCI) is a high-risk stage for progression to dementia. The SUPERBRAIN-MEET trial previously demonstrated cognitive benefits of a multidomain life...

1 January 2026 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
DKDa Ae Kim
Da Ae Kim
SLSun Min Lee
Sun Min Lee
KSKyunghwa Sun
Kyunghwa Sun
SKSeung joo Kim
Seung joo Kim
HKHyun Sook Kim
Hyun Sook Kim
SMSo Young Moon
So Young Moon
Kim DA, et al. J Clin Neurol. 2026 ;22:e43. https://doi.org/10.3988/jcn.2025.0635